Astera Labs, Inc. $ALAB Shares Sold by Caitong International Asset Management Co. Ltd

Caitong International Asset Management Co. Ltd cut its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 89.6% during the second quarter, HoldingsChannel reports. The firm owned 754 shares of the company’s stock after selling 6,531 shares during the period. Caitong International Asset Management Co. Ltd’s holdings in Astera Labs were worth $68,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Straight Path Wealth Management boosted its holdings in shares of Astera Labs by 1.5% in the second quarter. Straight Path Wealth Management now owns 6,850 shares of the company’s stock valued at $619,000 after acquiring an additional 100 shares in the last quarter. Wealthcare Advisory Partners LLC boosted its holdings in Astera Labs by 0.8% during the second quarter. Wealthcare Advisory Partners LLC now owns 29,160 shares of the company’s stock worth $2,637,000 after buying an additional 221 shares in the last quarter. Allworth Financial LP boosted its holdings in Astera Labs by 20.4% during the first quarter. Allworth Financial LP now owns 1,394 shares of the company’s stock worth $90,000 after buying an additional 236 shares in the last quarter. Sound Income Strategies LLC boosted its holdings in Astera Labs by 31.1% during the second quarter. Sound Income Strategies LLC now owns 1,038 shares of the company’s stock worth $94,000 after buying an additional 246 shares in the last quarter. Finally, GAMMA Investing LLC boosted its holdings in Astera Labs by 55.7% during the first quarter. GAMMA Investing LLC now owns 794 shares of the company’s stock worth $47,000 after buying an additional 284 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

Shares of ALAB stock opened at $164.97 on Friday. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90. The company has a 50 day moving average price of $196.79 and a 200 day moving average price of $131.41. The firm has a market capitalization of $27.42 billion, a price-to-earnings ratio of 294.59, a price-to-earnings-growth ratio of 4.08 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, topping the consensus estimate of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. During the same quarter in the prior year, the business posted $0.13 earnings per share. Astera Labs’s revenue for the quarter was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, equities analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insider Activity at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the completion of the sale, the director directly owned 385,863 shares in the company, valued at $66,858,482.01. The trade was a 32.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jitendra Mohan sold 91,441 shares of the business’s stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the sale, the chief executive officer owned 2,170,877 shares of the company’s stock, valued at approximately $398,377,638.27. This represents a 4.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,092,997 shares of company stock valued at $192,231,120 over the last quarter. Company insiders own 12.50% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently commented on the stock. Zacks Research downgraded shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a report on Monday, October 6th. CICC Research assumed coverage on shares of Astera Labs in a report on Friday, August 29th. They set an “outperform” rating and a $190.00 price objective on the stock. Wall Street Zen raised shares of Astera Labs from a “hold” rating to a “buy” rating in a report on Saturday, October 18th. Morgan Stanley boosted their price objective on shares of Astera Labs from $155.00 to $200.00 and gave the stock an “overweight” rating in a report on Friday, August 29th. Finally, Needham & Company LLC lifted their target price on shares of Astera Labs from $100.00 to $170.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $162.06.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.